Coca-Cola is facing a lawsuit over claims that its Simply Orange Juice contains high levels of toxic chemicals known as PFAS, or “forever chemicals.”
According to the plaintiff, Joseph Lurenz, the beverage company deceived customers by marketing the juice as all-natural, despite third-party testing finding PFAS levels hundreds of times higher than federal limits for drinking water.
Exposure to high PFAS levels can increase the risk of various health problems, including cancer, fetal complications, liver disease, kidney or testicular cancer, and increased cholesterol levels.
The plaintiff, which claims the defendants knew the product contained PFAS but failed to disclose the information to consumers, is seeking monetary compensation, damages, and penalties for the company.
It is unknown how PFAS chemicals contaminated the water used to make the juice, and if the chemicals could also be in the packaging.


Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 



